Colchysat® Bürger (Colchysat® Bürger Lösung) - Deutsch

Colchysat® Bürger Description, Presentation and Dosage

Colchysat® Bürger Description

Colchysat® Bürger Drug Class Description

Einzelstoffe

Colchysat® Bürger Drug Description

1 g enth.: Wässrig-ethanol. Preßsaft aus frischen Herbstzeitlosenblüten (1:15-25) 1 g (entspr. 0,5 mg Colchicin).

Colchysat® Bürger Generic Name

Colchysat® Bürger Lösung

Colchysat® Bürger Presentation

Colchysat® Bürger Presentation

Colchysat® Bürger

Colchysat® Bürger Manufacturer

Ysatfabrik

Updated

01 January 2000

Colchysat® Bürger Dosage

Colchysat® Bürger Precautions, Reactions and Contraindications

Colchysat® Bürger Special Precautions

Colchysat® Bürger Special Precautions

Eingeschränkte Nierenfunktion, Blutbildveränderungen (z. B. Anämie), Magen-Darmerkrankungen, eingeschränkte Herz-Kreislauf-Funktion, schlechter Allgemeinzustand (Polymorbidität), Lebererkrankungen. Kdr. und Jugendl.

Colchysat® Bürger Adverse Reactions

Colchysat® Bürger Adverse Reactions

Kontraind. Gr 8 .

Related News

PROTECT-AF trial of Watchman LAAC (Boston Scientific) successful for Stroke Prevention

Read more

Trial shows Vascazen (Pivotal Therapeutics) effective in altering cholesterol levels in patients with CV Risk

Read more

Four year follow up on EVEREST II study of Mitra Clip (Abbott)

Read more

FDA approves Liptruzet (Merck Inc) for Dyslipidaemia

Read more

Phase III trial shows benefits of Resolute ZES (Medtronic) in CAD patients with Diabetes

Read more

REMEDEE study of COMBO Dual Therapy Stent (Orbus Neich) meets primary endpoint

Read more

IQWiG report on Eliquis (BMS/Pfizer) for Stroke Prevention associated with Atrial Fibrillation

Read more

CHMP recommends Xarelto (Bayer) for prevention of atherosclerotic events after ACS

Read more

FDA approves AdreView (GE HealthCare) for gamma scintigraphic assessment of Heart Failure

Read more

CHMP restricts use of Pletal(Otsuka)and Ekistol(Lacer) to treat Intermittant Claudication

Read more

Recent Updates

Drugs

Read more

TAMPOSITORIEN® H

Read more

VENEN-SALBE N

Read more

ALLIOSAN®

Read more

TEGRA®

Read more

NITRANGIN COMPOSITUM

View all

Clinical Guidelines

Read more

Atrial fibrillation: National clinical guideline for management in primary and secondary care

Read more

Post Myocardial Infarction: Secondary prevention in primary and secondary care for patients following a myocardial infarction

Read more

Multiple sclerosis: National clinical guideline for diagnosis and management in primary and secondary care

Read more

Unstable angina and NSTEMI

View all

Medical Journals

Read more

Local Versus Epidural Anesthesia in Fast-Track Abdominal Aortic Surgery

Read more

β-Blockers and Volatile Anesthetics May Attenuate Cardioprotection by Remote Preconditioning in Adult Cardiac Surgery: A Meta-analysis of 15 Randomized Trials

Read more

Frequency of Coronary Angiography and Revascularization among Men and Women with Myocardial Infarction and Their Relationship to Mortality at One Year: An Analysis of the Geisinger Myocardial Infarction Cohort

Read more

Aortic Valve Stenosis: To the Gradient and Beyond—The Mismatch Between Area and Gradient Severity

epgonline.org Social

Back to top